Transaction structured to achieve majority ownership through performance-based clinical and regulatory milestonesMarks first strategic ...

InterVenn Biosciences, a precision diagnostics company advancing liquid biopsy with glycoproteomics, and Aranscia, a global provider of award-winning clinical workflow and diagnostic technology ...

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the instrumentation industry in ...

Truvian Health ("Truvian"), a transformational diagnostics company redefining healthcare, today announced the appointment of Michael J. Mina, MD, PhD, as Chief Medical and Strategy Officer. Dr. Mina, ...

Laboratory automation is bringing early diagnosis, improving the quality of healthcare, and reducing the burden on the healthcare system.

Global Serological Testing Market OverviewThe global serological testing market is projected to grow at a compound annual growth rate (CAGR) of approximately 6–8% through 2027. Market expansion is ...

Armed with some data from our friends at CrunchBase, I broke down the largest NYC Startup funding rounds in New York for ...

A new development in wireless sensing technology which can reliably screen for five common pulmonary diseases could lead to breakthrough new forms of touch-free diagnostics.

The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing ...

Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...

Molecular diagnostics drive global IVD growth as point-of-care solutions advance accessibility, with North America leading and Asia-Pacific emerging fastest through 2031 on chronic disease burden and ...